Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200039/S019

Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Cat

Shockwave Medical, Inc. · Decision date Feb 20, 2026

FDA DECISIONP200039/S019

What did the FDA approve?

FDA records P200039/S019 as a supplement to PMA P200039, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Feb 20, 2026.

FDA approval order statement

approval for the C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Catheter with higher pulse rate and shorter pause time than the C2 Aero Coronary Intravascular Lithotripsy (IVL) Catheter approved under P200039/S015
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Feb 20, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P200039/S019
Regulatory pathway
PMA supplement
Product code
QMG
Decision code
APPR
Decision date
Feb 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shockwave intravascular lithotripsy system.

Product code
QMG
FDA device class
3

For the original device and its historical approval scope, see PMA P200039. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200039 · Original PMA

    Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter

  2. P200039/S018 · Related supplement

    Shockwave lntravascular Lithotripsy {IVL) System with Shockwave C2/ C2+/ C2 Aero Coronary IVL Catheter

  3. P200039/S019 received

    Application receipt date recorded by FDA.

  4. P200039/S019 · FDA decision

    Normal 180 Day Track

  5. P200039/S020 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 Aero Coronary IVL Catheter

  6. P200039/S022 · Related supplement

    Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter; Sh

  7. P200039/S021 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 / C2+ / C2 Aero/ C2 Aero Fly Coronary IVL Catheter

  8. P200039/S023 · Related supplement

    Shockwave lntravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary IVL Catheter

  9. P200039/S025 · Related supplement

    SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH SHOCKWAVE C2/C2+ CORONARY IVL CATHETER

Timeline entries are records held by MedtechLedger for P200039. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200039

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shockwave Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5403 Betsy Ross Dr., Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records